0 CHECKOUT

3-D Matrix, Ltd. (7777) - Financial and Strategic SWOT Analysis Review

  • ID: 2051317
  • November 2015
  • 34 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Aushon BioSystems, Inc.
  • Capital Genomix, Inc
  • CellSeed Inc.
  • KAKETSUKEN
  • MORE

3-D Matrix, Ltd. (7777) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aushon BioSystems, Inc.
  • Capital Genomix, Inc
  • CellSeed Inc.
  • KAKETSUKEN
  • MORE

List of Tables

List of Figures

Section 1 - About the Company

3-D Matrix, Ltd. - Key Facts

3-D Matrix, Ltd. - Key Employees

3-D Matrix, Ltd. - Key Employee Biographies

3-D Matrix, Ltd. - Major Products and Services

3-D Matrix, Ltd. - History

3-D Matrix, Ltd. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

3-D Matrix, Ltd. - Business Description

3-D Matrix, Ltd. - Corporate Strategy

3-D Matrix, Ltd. - SWOT Analysis

SWOT Analysis - Overview

3-D Matrix, Ltd. - Strengths

Strength - Widespread Geographical Presence

Strength - Technology Platform

Strength - Partnerships

3-D Matrix, Ltd. - Weaknesses

Weakness - Declining Financial Performance

3-D Matrix, Ltd. - Opportunities

Opportunity - Emerging Markets

Opportunity - Field Cases of Research

Opportunity - Product Pipeline

3-D Matrix, Ltd. - Threats

Threat - Fierce Competition

Threat - Stringent Government Regulations

Threat - Uncertain R&D Outcomes

3-D Matrix, Ltd. - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015

3-D Matrix, Ltd., Recent Deals Summary

Section 5 – Company’s Recent Developments

Jan 28, 2014: 3-D Matrix Files Patent Infringement Complaint Against Menicon and B-Bridge International

Section 6 – Appendix

Methodology

Ratio Definitions

About Us

Contact Us

Disclaimer

List of Tables

3-D Matrix, Ltd., Key Facts

3-D Matrix, Ltd., Key Employees

3-D Matrix, Ltd., Key Employee Biographies

3-D Matrix, Ltd., Major Products and Services

3-D Matrix, Ltd., History

3-D Matrix, Ltd., Subsidiaries

3-D Matrix, Ltd., Key Competitors

3-D Matrix, Ltd., Ratios based on current share price

3-D Matrix, Ltd., Annual Ratios

3-D Matrix, Ltd., Interim Ratios

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015

3-D Matrix, Ltd., Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

3-D Matrix, Ltd., Performance Chart (2011 - 2015)

3-D Matrix, Ltd., Ratio Charts

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

3-D Matrix, Ltd., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015

Note: Product cover images may vary from those shown
3 of 4

Capital Genomix, Inc
KAKETSUKEN
CellSeed Inc.
Aushon BioSystems, Inc.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.